The lecithin:cholesterol acyltransferase (LCAT) enzyme is responsible for the synthesis of cholesteryl esters in human plasma and plays a critical role in high density lipoprotein (HDL) metabolism. Genetic LCAT deficiency is a rare metabolic disorder characterized by low HDL cholesterol levels. This paper reviews the genetic and biochemical features of LCAT deficiency, highlighting the absence of enhanced preclinical atherosclerosis in carriers, despite the remarkably low HDL cholesterol.
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease / L. Calabresi, S. Simonelli, M. Gomaraschi, G. Franceschini. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 222:2(2012), pp. 299-306.
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
L. CalabresiPrimo
;S. SimonelliSecondo
;M. GomaraschiPenultimo
;G. FranceschiniUltimo
2012
Abstract
The lecithin:cholesterol acyltransferase (LCAT) enzyme is responsible for the synthesis of cholesteryl esters in human plasma and plays a critical role in high density lipoprotein (HDL) metabolism. Genetic LCAT deficiency is a rare metabolic disorder characterized by low HDL cholesterol levels. This paper reviews the genetic and biochemical features of LCAT deficiency, highlighting the absence of enhanced preclinical atherosclerosis in carriers, despite the remarkably low HDL cholesterol.File | Dimensione | Formato | |
---|---|---|---|
2012 Ath-Calabresi-LCATdefReview.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
484.26 kB
Formato
Adobe PDF
|
484.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.